A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
To observe the decreased levels of low-density lipoprotein from baseline in patients with obesity-related glomerulopathy (ORG) after 12 weeks of Sevelamer Carbonate treatment.
Epistemonikos ID: 19be727f9467530265447404a524f993a9ef59a6
First added on: May 12, 2024